Erythema Nodosum

Erythema nodosum (EN) is the most common form of panniculitis, characterized by painful, erythematous, subcutaneous nodules, typically localized to the anterior shins. It represents a delayed hypersensitivity reaction to various antigenic stimuli, including infections, medications, and systemic inflammatory diseases.

EN is a reactive process. Common triggers include streptococcal pharyngitis, sarcoidosis, inflammatory bowel disease (IBD), tuberculosis, Coccidioidomycosis, and drug reactions (e.g., sulfonamides, oral contraceptives). Genetic predisposition is linked to HLA-B27, HLA-B8, and HLA-DRB1*0
302.

The process involves a septal panniculitis—inflammation of the connective tissue septa between subcutaneous fat lobules. Immune complex deposition (Type III hypersensitivity) triggers localized inflammation, neutrophil infiltration, and release of proinflammatory cytokines (TNF-alpha), leading to vascular injury and the characteristic nodular appearance.

EN occurs at any age but is most frequent between 20 and 40 years. It shows a significant female predilection (3:1 to 5:1 ratio).

• Recent streptococcal infections
• Pregnancy
• Oral contraceptive use
• Personal or family history of sarcoidosis or IBD
• Exposure to endemic fungal pathogens (e.g., Histoplasmosis)

A. Early Symptoms

• Mild fever


• Malaise


• Arthralgia (joint pain)


• Tenderness at the pretibial sites B. Common Symptoms


• Painful, firm, red nodules (1-5 cm)


• Symmetrical distribution on the anterior shins


• Lesions resembling bruises that change color (erythema to violaceous to brownish) C. Advanced Symptoms


• Extensive skin involvement


• Persisting joint swelling


• Migratory lesions (Erythema nodosum migrans) D. Emergency Symptoms


• High-grade systemic fever


• Severe respiratory distress (if underlying sarcoidosis or tuberculosis is present)

• Inspection: Reddish, shiny, non-ulcerating nodules.
• Palpation: Extremely tender, firm, warm lesions.
• Joints: Possible ankle or knee swelling.
• Vital signs: Low-grade fever may be present.

A. Clinical Assessment: Primarily diagnosis of exclusion based on clinical presentation.
B. Laboratory Testing: Targeted to identify underlying triggers.
C. Imaging Studies: Chest X-ray to screen for sarcoidosis or tuberculosis.
D. Functional Tests: Not standardly required.
E. Biopsy Findings: Septal panniculitis without vasculitis.
F. Genetic Testing: Generally unnecessary.
G. Differential Diagnosis: Cellulitis, polyarteritis nodosa, erythema induratum.

Test Name: Antistreptolysin O (ASO) Titer
Type: Blood Test
Purpose: Screen for recent Group A Strep infection
Expected Findings: Elevated
Interpretation: Indicates possible post-streptococcal etiology Test Name: QuantiFERON-TB Gold
Type: Blood Test
Purpose: Rule out Tuberculosis
Expected Findings: Negative (in most cases)
Interpretation: Negative result helps exclude TB-associated EN

• Chest X-ray (CXR): Essential to detect bilateral hilar adenopathy (indicative of sarcoidosis) or pulmonary infiltrates (TB/fungal).

• Cellulitis: Usually unilateral, hot, and involves the epidermis.
• Polyarteritis Nodosa: Involves deep cutaneous arteries and systemic symptoms.
• Erythema Induratum: Usually occurs on the posterior calf and ulcerates.

• Chronic panniculitis
• Secondary infection (if skin integrity is compromised)
• Chronic joint pain

A. Lifestyle Modifications: Bed rest, leg elevation, compression stockings.
B. Preventive Measures: Avoidance of known trigger medications.
C. Medical Treatment:

• NSAIDs (e.g., Naproxen): First-line for pain.


• Potassium Iodide: Effective for chronic cases.


• Systemic Corticosteroids: Reserved for severe cases when infection is excluded. D. Surgical Treatment: Not applicable.

Generally self-limiting, resolving within 3 to 6 weeks. Lesions heal without scarring or atrophy. Recurrence is possible if the underlying trigger persists.

• Treating identified infections
• Modifying medication regimens

The following homeopathic remedies have been historically indicated for symptoms associated with Erythema Nodosum. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Erythema Nodosum.